CannabisLink.ca - Top Stories

Top Stories (2026) - (1776 items)

(All links open in new tab)

Oct 27, 2026	Zimbabwe Slashes Sky-High Medical Cannabis Fees In a bid to increase licence applications and foster national growth, the Government of Zimbabwe has reduced medical cannabis licensing fees by as much as 90%.
Oct 27, 2026	Marijuana Users Trust Dispensary Staff More Than Doctors Or The Government For Cannabis Info, Federally Funded Study Shows People who consume marijuana trust dispensary staff more than healthcare providers or government agencies as a source of information about cannabis, according to a new federally funded study. Researchers with the University of California, Johns Hopkins University and other institutions conducted an online survey of 1,023 U.S. residents over the age of 18 who used a THC-containing cannabis product in the past month, asking them to rate the level of trust they place in several sources of information about marijuana.
Oct 26, 2026	New complete cannabis genomes reveal how THC and CBD genes evolved Despite the therapeutic importance of cannabinoids, the scarcity of gap-free Cannabis genomes has limited the dissection of the genetic and genomic basis of cannabinoid biosynthesis and genome evolution.
Oct 26, 2026	The Most Important Room In International Cannabis On November 9th, at The Savoy in London, the Talman Group will host its fall members-only investor gathering. On paper, it’s a one-day program. Panels in the morning, startup pitches after the break, and a fireside chat to close. Look at the speaker list, though, and something else becomes evident.
Oct 26, 2026	From Compliance to Competitive Advantage: How AI Is Transforming Cannabis Operations Cannabis businesses already collect enormous amounts of data. Learn how AI is helping operators turn that information into faster decisions, stronger inventory management, improved compliance visibility, and greater profitability.
Oct 26, 2026	Brazil Has 1 Million Medical Cannabis Patients. Its Biggest Cannabis Fair Is Thinking Bigger Brazil doesn’t have adult-use cannabis. It doesn’t even have a full domestic cultivation market yet. What it does have, as of June 2026, is more than one million recurring medical cannabis patients, according to market research firm Kaya Mind. That’s 1,012,887 people, spread across roughly 90% of the country’s municipalities. That number is the backdrop for the fourth edition of ExpoCannabis Brasil, running Friday, November 20 through Sunday, November 22 at the São Paulo Expo. Organizers expect close to 50,000 visitors and 344 exhibitor booths, up 38% from last year, when 45,000 people came through over three days.
Oct 26, 2026	Cannabis Cultivators of British Columbia Welcomes New B.C. Conservative Government and Commitment to Cannabis Economic Development VANCOUVER, British Columbia, Oct. 26, 2026 (GLOBE NEWSWIRE) -- The Cannabis Cultivators of British Columbia (CCBC) congratulates Premier Doerkson and the newly elected B.C. Conservative government and welcomes its commitment to recognize cannabis as an economic development and job-creation opportunity for British Columbia. The Conservative platform commits to moving responsibility for cannabis into Economic Development and developing a strategy focused on economic growth and job creation. CCBC strongly welcomes this direction and looks forward to working with the new government to put it into action.
Oct 26, 2026	Institutional Investors Eye Cannabis, But Regulatory Hurdles Remain nstitutional investors are warming to US cannabis stocks, but most still aren’t putting new money in, and the wait for federal rescheduling just got longer. That matters because rescheduling is what investors are waiting on, according to Frederico Gomes, cannabis analyst at ATB Cormark Capital Markets. “There’s nothing else that can actually move these stocks,” Gomes told the Investing News Network on October 14. “In terms of actually attracting more institutional capital into this sector, you really need regulatory reform.”
Oct 26, 2026	South African grower starts cultivation as the regulatory framework evolves In South Africa, licensed cannabis producers and the regulatory framework they answer to are still growing up together. For a couple in Cape Town, that meant three years with the same facility on their minds, from the first plans to a license that arrived in August 2026, after a process that started in December 2024 and took a little more than a year and a half to complete. "One of the main challenges was the lack of clear guidance on certain processes and expected turnaround times. This made planning more difficult, but we kept working through the requirements, and our focus was to bring the right expertise into the business as we were adapting," says Kim Praizovic, who co-founded CannaGrit with her husband.
Oct 26, 2026	Can Tourists Legally Buy Marijuana? Cannabis Laws Across All 50 States Travelers planning trips across the United States have a new resource to help navigate marijuana laws, with a recently released guide outlining where visitors can legally purchase cannabis and what restrictions apply in each state. Alexis 420, a directory of licensed cannabis dispensaries, has published a 50-state cannabis travel guide covering purchasing requirements, identification rules, taxes, and restrictions impacting out-of-state visitors.
Oct 26, 2026	From Endometriosis to Back Pain: The Medical Cannabis Trials to Watch in 2026 Could CBD help the one in ten women living with the excruciating pain caused by endometriosis? Could it ease the nerve symptoms that persist after chemotherapy? And how does a cannabis-based medicine compare with opioid painkillers? These questions are driving clinical research across the UK and Europe, with some programmes recruiting patients and others already producing results. In Scotland, two studies are investigating the same CBD formulation for different conditions.
Oct 26, 2026	Aurora Cannabis Announces the Alberta Securities Commission has dismissed Curaleaf's Application and ruled in favour of the Company's At-the-Market Program EDMONTON, AB, Oct. 26, 2026 /PRNewswire/ -- Aurora Cannabis Inc. ("Aurora" or the "Company") (ACB) (ACB), the Canadian-based leading global medical cannabis company, today shared that the application made by Curaleaf Holdings, Inc. ("Curaleaf") (CURA) (OTCQX: CURLF) to halt Aurora's at-the-market ("ATM") program was dismissed by the Alberta Securities Commission. This positive result supports Aurora's view that Curaleaf's actions were simply to distract shareholders from the fundamental issue before them: Curaleaf's hostile bid significantly undervalues Aurora and seeks to acquire Aurora's cash, unique EU-GMP assets, global growth platform and future upside at a discount.
Oct 26, 2026	Legal Medical Cannabis Means Better, Not Weaker, Health Protection Germany has, without question, the most progressive regulation of medical cannabis in the EU. Yet, the current federal government’s Ministry of Health, led by the CDU, wants to significantly restrict telemedical access to medical cannabis and specifically flowers, citing abuse. On closer inspection, there is still no supporting data or evidence for this.
Oct 26, 2026	‘They buy because it’s easy’: Legal shops want more than enforcement to fight illegal pot Though the Ford government says it’s planning to introduce new measures to crack down on illicit cannabis sales, legal retailers are questioning why it took eight years following legalization for enforcement tools to be bolstered. Several legal sellers told Global News they want Ontario to take the new rules a step further, by allowing the legal market to innovate and modernize cannabis sales by lifting some restrictions on how and where pot can be sold.
Oct 25, 2026	Polish Study Finds CBD To Be Beneficial For Post-Exercise Recovery Sports and athletics have been the focus of anti-cannabis propaganda for decades. Professional athletes are prominent in societies worldwide, so it’s no coincidence that anti-cannabis campaigns have incorporated professional leagues and athletes. Those anti-cannabis campaigns were based on the false premise that cannabis use is always bad, including cannabis use by professional and amateur athletes. Thankfully, many professional sports leagues have now abandoned testing for cannabis. Furthermore, cannabis research is establishing that cannabis can be beneficial for athletes. A recent example is a study led by researchers in Poland who examined the efficacy of cannabidiol (CBD) for post-exercise recovery. The study’s findings were published in the International Medical Journal and initially reported by Marijuana Moment.
Oct 25, 2026	Your body makes its own cannabis-like chemicals as you run, and neuroscience research finds they keep rising all the way to the marathon finish line, a possible clue to the runner’s high A long run appears to keep the body’s own cannabis-like chemical messengers active for hours. New research published in BMC Medicine indicates that one of these compounds, anandamide, climbs steadily during a marathon and stays elevated 45 minutes after the finish, and that levels are also higher after ultramarathons of up to 230 kilometers. These chemical changes occurred alongside shifts in mood, such as reduced anxiety after running, although the study did not test whether one caused the other.
Oct 24, 2026	Cannabis drinks boom sparks rift in US alcohol industry Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.com T&Cs and Copyright Policy. Email licensing@ft.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the gift article service. More information can be found at https://help.ft.com/faq/gifting-and-sharing-an-article/what-is-a-gift-article/. https://www.ft.com/content/a4d00561-9309-427d-a5b7-556c2b4a74e8?syn-25a6b1a6=1 The rapid rise of THC-infused beverages has put US alcohol producers at odds with wholesalers and drinks retailers, as a growing number of consumers turn their backs on booze for a mellower high. Struggling brewers and distillers, mindful of the threat of an emerging competitor, have been calling for tough regulation of drinks containing THC, the primary psychoactive compound in cannabis. However, drinks distributors and retailers are pushing for forthcoming restrictions on the beverages to be overturned for fear of losing sales.
Oct 24, 2026	DEA Judge Denies Marijuana Rescheduling Opponents’ Request To Reopen Hearing For More Testimony, But Allows New Briefs A Drug Enforcement Administration (DEA) judge has rejected marijuana rescheduling opponents’ request to reopen an ongoing hearing on the Trump administration’s proposed reform for a new round of testimony and document discovery—but he is allowing a federal watchdog report that found there are “gaps” in the government’s process for evaluating controlled substances to be entered into the record and is inviting parties to submit additional briefs about it.
Oct 23, 2026	Gene-Edited Cannabis Is Already Here. Who Gets to Own It? F1 seed, triploids, genomic testing and gene editing are changing cannabis from the breeding tent to the corporate laboratory. The tools are shared. Access and control of the genetic library are not. Jorge Cervantes and his co-authors separate the promises from the proof.
Oct 23, 2026	Canada Cannabis Sales Reach New High in August 2026 Canada’s cannabis sales reached a new high in August 2026, totalling $520.4 million. Dried flower sales have also slightly rebounded in terms of units sold, while cannabis edibles increased and extracts declined. The new preliminary figures show national cannabis sales up about 3% year-over-year from $503.1 million in August 2025. Statistics Canada routinely updates its sales figures over time as new data comes in. As a result, July 2026 sales figures have been adjusted from $503.2 million to $515.8 million, a 3% increase.
Oct 23, 2026	How Low Can It Go: What You Need to Know About Cannabis Price Compression What Is Cannabis Price Compression? It's when retail prices plummet. This has happened in most legal states so far. Competitors who sell pretty much the same products due to lack of interstate commerce under federal law begin to drop prices to gain an edge and others eventually follow. It's also a response to illegal sales of cannabis products, which are usually cheaper than legal ones. For instance, in Massachessetts, which borders New York, the average price of flower is $14 per eight and $80-$150 per ounce. In New York, similar products go for $33 per eighth and $170-$320 per ounce. In Califonia, ounces sell for as low as $60. These are all big drops from when the legal markets opened. New York retailers are hoping prices will stay relatively high, unlike in most of the legal states
Oct 23, 2026	Israel Names Four Canadian Cannabis Companies for Anti-Dumping Investigation srael’s Commissioner for Trade Levies at the Ministry of Economy and Industry says it will investigate four Canadian cannabis companies in its latest probe into accusations of “product dumping.” In an October 22 announcement, the Commissioner named four companies: GrowCo, Cielo Verde Quebec Inc., 2323414 Alberta Ltd., and Koots Canna Ltd., which it identifies as being responsible for most of the cannabis being exported from Canada into Israel’s medical cannabis market.
Oct 23, 2026	Prominent Virginia senator charged over allegations she ran criminal cannabis scheme Federal prosecutors arrested a prominent Virginia lawmaker on Thursday over allegations she oversaw a criminal cannabis enterprise. Lucas and her alleged co-conspirators are charged with obtaining and illegally distributing large amounts of illegal cannabis. The government has also accused her of using her political influence to benefit herself and her family.
Oct 22, 2026	Survey: German Patients Overwhelmingly Prefer Cannabis From Pharmacies A survey of 7,913 German medicinal cannabis patients, almost 90% of whom have experience with both the unregulated and regulated markets, found that an overwhelming majority of them prefer making their medical cannabis purchases from pharmacies. Bloomwell Group GmbH, one of Europe’s leading medical cannabis companies, conducted the survey.
Oct 22, 2026	Cronos Completes the Acquisition of CanAdelaar for 57.5 million euros The Canadian brand Cronos has finalized the ’Full acquisition of CanAdelaar, one of the largest licensed cannabis producers in the Netherlands, for a base price of 57.5 million euros. This acquisition establishes Cronos as a leader in the Dutch cannabis regulatory landscape and strengthens its presence in Europe.
Oct 22, 2026	Sorry Washington, You Can’t Beat the Gray Market Governments think they can eliminate demand by banning supply. That misunderstands how gray and black markets operate. Texas has spent decades prosecuting marijuana possession. Now, in Austin, someone carrying certain delta-8 THC gummies can face a felony charge, while possession of a small amount of marijuana is generally treated as a lower enforcement priority.
Oct 22, 2026	DEA Judge Denies Marijuana Rescheduling Opponents’ Request To Reopen Hearing For More Testimony, But Allows New Briefs A Drug Enforcement Administration (DEA) judge has rejected marijuana rescheduling opponents’ request to reopen an ongoing hearing on the Trump administration’s proposed reform for a new round of testimony and document discovery—but he is allowing a federal watchdog report that found there are “gaps” in the government’s process for evaluating controlled substances to be entered into the record and is inviting parties to submit additional briefs about it.
Oct 22, 2026	Hemp: The Council of the EU Takes a Stand on New Production and Marketing Rules The Council of the European Union has agreed on a negotiating position that could redefine the legal framework for industrial hemp at the European level. Whether it involves recognizing more parts of the cannabis plant Whether it is treating cannabis as an agricultural product or harmonizing THC requirements, the proposed changes represent a significant step forward for the sector, without, however, eliminating current national restrictions and regulatory uncertainty.
Oct 22, 2026	Poll: 78% of Cannabis Consumers Base Their Votes on Candidates’ Cannabis Policy Nearly 80% of cannabis consumers say that a candidate’s view on cannabis policy will determine whether they will vote for them during November’s midterm elections, according to a poll released Tuesday by NuggMD at the request of NORML. Forty-one percent of respondents said a candidate’s views on cannabis would “significantly” influence their decision to vote for them in November, while 37% said a candidate’s views on cannabis would “somewhat” influence their decision. Twenty-two percent of those polled said that a candidate’s views on cannabis would not influence their decision at all.
Oct 22, 2026	Puff, puff, don’t pass? Study says frequent weed users share less Cannabis has long been a communal experience, with ‘puff, puff, pass’ serving as an unofficial mantra. But a recent study suggests some consumers may be more inclined to bogart their bud. The research, published in the journal Experimental and Clinical Psychopharmacology, found that college students who use cannabis frequently were less likely to share a hypothetical stash and more prone to solitary consumption.
Oct 22, 2026	Marijuana use rises sharply among one group of Americans, new study finds A growing number of American parents are using cannabis, prompting questions about potential child exposure and safety, according to a new study. Cannabis use increased substantially among parents between 2012 and 2024, with researchers estimating that at least 5.9 million U.S. children were living with a parent who used marijuana on most days in 2024. By 2024, 8% of parents used cannabis on most days, 5.2% used it daily and 6.7% met the criteria for cannabis use disorder (CUD).
Oct 21, 2026	Cannabis for Chronic Pain: The Question Isn’t Just Whether It Works, but for Whom A two-year study of 3,744 patients with chronic pain found significant improvements in pain, sleep quality, anxiety and overall quality of life among those using medical cannabis. More than half of the patients with pain assessments recorded at 24 months achieved a clinically meaningful reduction in pain, although the study’s observational design means the findings show an association rather than proving causation.
Oct 21, 2026	Lots of People Turn to Marijuana to Quit Cigarette Smoking, VA Study Finds A new study has found that cannabis is nearly as common as prescription medication among people seeking help to stop smoking cigarettes. Researchers from the U.S. Department of Veterans Affairs, New York University, the San Francisco VA Health Care System, and the University of California examined survey responses from 2,804 adults who either used nicotine e-cigarettes, smoked cigarettes, or did both.
Oct 21, 2026	Patients waiting indefinitely for medicine two years after Nebraskans approved medical cannabis Voters approved two measures. The Nebraska Medical Cannabis Patient Protection Act allows medical patients to possess up to 5 ounces of cannabis with the recommendation of a healthcare practitioner. The Nebraska Medical Cannabis Regulation Act created the Nebraska Medical Cannabis Commission to govern the state’s program.
Oct 21, 2026	This Cannabis Stock Jumped 12% in a Day: The Math Says Be Careful Record revenue can make a struggling stock look ready for a comeback. The important question is what remains after the business pays its costs and funds the investment needed to keep operating. Tilray Brands (TSX: TLRY) reported record first-quarter revenue on October 8. The business expanded beyond cannabis into beverages and distribution. That makes the headline growth interesting, but the cash figures give investors a much more cautious conclusion.
Oct 21, 2026	A brewing inflation tale: Beer prices soar in Ontario, while the cost of cannabis stays low As the cost of cracking open a beer climbs in Ontario, cannabis users have seen smaller price increases over the past year. The price of beer in Ontario rose 10.2 per cent in August 2026 compared to the same month in 2025, according to a Capital Current’s analysis of Statistics Canada’s Consumer Price Index. Recreational cannabis prices, however, only increased 1.6 per cent in the same period, Capital Current found. The small increase in cannabis prices follows yearly declines. When these trends are compared to nation-wide data, the numbers tell a similar story, with beer purchased from stores increasing by 4.7 per cent and recreational cannabis prices decreasing one per cent.
Oct 21, 2026	Germany’s Hemp Intoxication Clause Creates Unnecessary Risk For Farmers Germany is on a short list of countries that have adopted a national adult-use cannabis legalization measure. Starting on April 1st, 2024, adults in Germany can cultivate, possess, and consume personal amounts of cannabis. Those adult consumers’ recreational cannabis does not have a THC content limit. With that in mind, it is illogical for Germany’s government to continue to cling to its arbitrary low-THC limit for industrial hemp. Germany has permitted industrial hemp cultivation since 1996. The THC threshold for industrial hemp in Germany is 0.3%.
Oct 21, 2026	Study suggests price is the deciding factor in where cannabis users shop Legal marijuana is now a multibillion-dollar business across the U.S., but the illicit market remains a major competitor to dispensaries in many places. According to new research out of Missouri, 93% of reported cannabis spending in the state went through the regulated market But among those who still bought from illicit sellers, 62% said lower prices were the main reason.
Oct 21, 2026	Ontario proposes tougher crackdown on illegal cannabis sales The Ontario government is proposing tougher enforcement measures to crack down on illegal cannabis sales and protect consumers. The planned changes would give the Alcohol and Gaming Commission of Ontario new powers to inspect unauthorized storefronts and online retailers, seize illegal products and equipment, and issue monetary penalties.
Oct 21, 2026	Spain’s Medical Cannabis Framework Finally Reaches Patients, But Rollout is ‘Not the Finish Line’ Spain’s medical cannabis framework will finally start reaching patients over the coming days and weeks, marking a significant milestone in a four-year battle for access. In June 2022, we reported that ‘the regulation and distribution of medical cannabis’ could be rolled out in Spain ‘by the end of the year’, following a knife-edge vote to push through proposals for a framework. Now, more than four years later, and over a year since the Royal Decree 903/2025 came into force, the first (and only) two preparations will be delivered to around 50 public and private hospitals this week, with a broader national rollout expected by the end of October 2026.
Oct 21, 2026	Canadian Cannabis Suppliers Adapt to Tariffs and Economic Uncertainty For Canadian companies supplying the cannabis industry, the effects of current US/Canada trade tensions begin well before products reach a dispensary shelf. Packaging materials and production equipment regularly move through cross-border supply chains, bringing tariffs into purchasing decisions on both sides of the border.
Oct 20, 2026	Magistrate warns cannabis still illegal Magistrate Jared Richards warned that cannabis remains illegal in Barbados as he placed 25-year-old Kemar Aykeem Bruce on a three-month bond to keep the peace for drug offences. Placing him on the bond for the offence of intending to supply, Magistrate Richards said: “You must understand that marijuana is still illegal, but the law reflects that if you have 14 grammes or less, you will get a ticket and pay a fine rather than be brought to court. So put it in your mind that it is still illegal even though I find some persons are believing now that it isn’t, but it is and that is how you ended up here.”
Oct 20, 2026	Recent Studies Debunk Anti-Cannabis Industry Talking Points A trio of recent studies provides evidence that directly contradicts major talking points that are often used by special interests opposed to the legal cannabis industry. The first pertains to crime, the second to youth cannabis consumption, and the third to motor vehicle safety. Cannabis industry opponents frequently make the claim that if legal cannabis sales are permitted, a spike in crime will occur in the area surrounding where legal sales are allowed. A researcher at Brock University examined crime data in Toronto and Ottawa, where adult-use cannabis sales are legal. His findings were published in The International Journal of Drug Policy.
Oct 20, 2026	Trump losing ground with cannabis consumers ahead of midterms Cannabis consumers are increasingly dissatisfied with the Trump administration’s handling of marijuana policy. A recent poll shows major declines among the demographic, as advocates continue to wait for broader reform and a hemp ban looms. The survey from NuggMD and Marijuana Moment revealed that 29 percent of cannabis consumers either approve or strongly approve of the administration’s actions on the plant. That’s a major drop from the July quarterly poll, when support was 48 percent.
Oct 20, 2026	Opening Legal Marijuana Dispensaries Provides An Economic Boost For Nearby Businesses, Study Shows The opening of recreational marijuana dispensaries can help boost nearby businesses by increasing foot traffic, purchases and revenue, according to a new study. Researchers from the City University of New York, Northern Illinois University and University of Miami examined cannabis market growth, credit and debit card purchases and socioeconomic and demographic data in Illinois from 2021 through 2024, finding that “recreational dispensary openings increase the number of customers at nearby establishments by approximately 6.82%, transactions by 8.01%, and revenue by 7.47%.”
Oct 19, 2026	Study Finds THC-Rich Marijuana Extracts Trigger Leukemia Cell Death and Immune-Response Signals THC-rich marijuana extracts triggered programmed cell death in leukemia cells while activating biological signals associated with immune recognition of cancer, according to new research accepted for publication in Frontiers in Immunology. The study, conducted by researchers affiliated with the Juan N. Corpas University Foundation in Bogotá, Colombia, examined how marijuana extracts with different THC and CBD concentrations affected two human leukemia cell lines and the activity of immune cells known as macrophages.
Oct 19, 2026	Legal Retailers Welcome Ontario’s Plan to Target Illegal Cannabis Shops The Ontario government says it plans to strengthen enforcement against illegal cannabis sales in the province. The proposed changes will be part of an upcoming legislative package. They would give the Alcohol and Gaming Commission of Ontario (AGCO) new tools to address unauthorized cannabis storefronts and unlawful online retail operations, including the authority to conduct inspections, seize illegal cannabis products and equipment, and issue administrative monetary penalties.
Oct 19, 2026	NORML Files Amicus Brief in Case Over Enforceability of Cannabis-Related Contracts Members of the NORML Legal Committee – led by attorney William Swor of Detroit, Michigan – have filed a friend-of-the-court (amicus) brief urging the US Court of Appeals for the Sixth Circuit to reconsider its decision that cannabis industry contracts are not enforceable as long as marijuana is federally prohibited. Specifically, the Appeals Court ruled in September that federal courts cannot award breach-of-contract damages in situations that enforce an agreement specific to conduct that is prohibited by the US Controlled Substances Act.
Oct 19, 2026	European Cannabis at the Crossroads: Regulation Across Borders The 2026 report from the European Union Drugs Agency (EUDA) highlights that cannabis policies in Europe are evolving at varying rates and in different directions. Germany, Malta and Spain have established different frameworks for adult-use cannabis; Luxembourg and Czechia have introduced limited home cultivation, while the Netherlands is testing regulated cannabis supply. At the same time, other countries maintain much more restrictive approaches.
Oct 19, 2026	Here’s the Hands-Down Best Cannabis Stock for Dividend Investors Many income investors wouldn't go near a pot stock with a 10-foot pole -- and for good reason. For one thing, most cannabis stocks don't pay dividends. The ones that do operate in a highly volatile industry. However, it's important to remember the adage "don't throw the baby out with the bath water." Sure, most cannabis stocks aren't good picks if you're seeking reliable income. There's one, though, that I think is hands-down the best cannabis stock for dividend investors. If you want cannabis exposure without cannabis-company risk, along with an exceptionally juicy yield, check out Innovative Industrial Properties 9.00% Series A Cumulative Redeemable Preferred Stock (NYSE: IIPR-PA).

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36